Viridian Therapeutics, Inc.

NasdaqCM:VRDN Stock Report

Market Cap: US$1.2b

Viridian Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Steve Mahoney

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure3.3yrs

Recent management updates

Recent updates

Despite Lacking Profits Viridian Therapeutics (NASDAQ:VRDN) Seems To Be On Top Of Its Debt

Sep 12
Despite Lacking Profits Viridian Therapeutics (NASDAQ:VRDN) Seems To Be On Top Of Its Debt

Is There An Opportunity With Viridian Therapeutics, Inc.'s (NASDAQ:VRDN) 44% Undervaluation?

May 15
Is There An Opportunity With Viridian Therapeutics, Inc.'s (NASDAQ:VRDN) 44% Undervaluation?

Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?

Apr 18
Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?

Does Viridian Therapeutics (NASDAQ:VRDN) Have A Healthy Balance Sheet?

Jan 08
Does Viridian Therapeutics (NASDAQ:VRDN) Have A Healthy Balance Sheet?

Viridian: Excellent Early Data, Strong Cash, Great Strategy, Large Market

Sep 09

Viridian Therapeutics board compensation committee approves inducement grants

Sep 02

An Intrinsic Calculation For Viridian Therapeutics, Inc. (NASDAQ:VRDN) Suggests It's 49% Undervalued

Aug 22
An Intrinsic Calculation For Viridian Therapeutics, Inc. (NASDAQ:VRDN) Suggests It's 49% Undervalued

Viridian Therapeutics Q2 2022 Earnings Preview

Aug 12

Viridian Therapeutics gets a new COO

Jun 23

Viridian Therapeutics (VRDN) Investor Presentation - Slideshow

Jun 08

Viridian Therapeutics reports Q1 results

May 06

CEO

Steve Mahoney (52 yo)

less than a year

Tenure

Mr. Stephen F. Mahoney, also known as Steve, J. D., serves as President, CEO & Director at Viridian Therapeutics, Inc. since October 30, 2023. He served as President at Magenta Therapeutics, Inc. since Feb...


Leadership Team

NamePositionTenureCompensationOwnership
Stephen Mahoney
CEO, President & Directorless than a yearno datano data
Eric Olson
Co-Founder & Chairman of Scientific Advisory Boardno datano datano data
Michael Bristow
Co-Founder & Member of the Scientific Advisory Boardno datano datano data
Marvin Caruthers
Co-Founder & Scientific Advisory Board Memberno datano datano data
Vahe Bedian
Co-Founder & Scientific Advisorno datano datano data
Seth Harmon
Senior VP of Finance and Accountingless than a yearno datano data
Thomas Beetham
Chief Operating Officerless than a yearno datano data
Jennifer Tousignant
Chief Legal Officerno datano datano data
John Jordan
Vice President of Investor Relations & Corporate Communicationsno datano datano data
Anthony Casicano
Chief Commercial Officerless than a yearno datano data
Thomas Ciulla
Chief Medical Officer1.1yrsno data0.0013%
$ 14.7k
Shan Wu
Chief Business Officerless than a yearno datano data

0.3yrs

Average Tenure

56yo

Average Age

Experienced Management: VRDN's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Stephen Mahoney
CEO, President & Directorless than a yearno datano data
Eric Olson
Co-Founder & Chairman of Scientific Advisory Boardno datano datano data
Michael Bristow
Co-Founder & Member of the Scientific Advisory Boardno datano datano data
Marvin Caruthers
Co-Founder & Scientific Advisory Board Memberno datano datano data
Arlene Morris
Independent Director6.1yrsUS$174.80k0%
$ 0
Victor Ambros
Scientific Advisory Board Memberno datano datano data
Stefanie Dimmeler
Scientific Advisory Board Memberno datano datano data
Jeffery Molkentin
Scientific Advisory Board Memberno datano datano data
Eva van Rooij
Scientific Advisory Board Memberno datano datano data
Tomas Kiselak
Independent Chairperson of Board3.3yrsUS$192.30k0%
$ 0
Jennifer Moses
Independent Director2.6yrsUS$168.30k0%
$ 0
Peter Harwin
Independent Director3.3yrsUS$168.80k0%
$ 0

3.3yrs

Average Tenure

52yo

Average Age

Experienced Board: VRDN's board of directors are considered experienced (3.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.